| Symbol | MYNDF |
|---|---|
| Name | MYND LIFE SCIENCES INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V3C 2B2 Canada BC 105 - 2248 Elgin Ave. |
| Telephone | +1 604 813 9795 |
| Fax | — |
| — | |
| Website | https://myndsciences.com/ |
| Incorporation | CA |
| Incorporated On | 2020 |
| Employees | — |
| Fiscal Year | 10/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | MNP LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | — |
| Description | Mynd is a life sciences based neuro-pharmaceutical drug development company advancing medicines that leverage psychedelic compounds. Our mission is to further our existing research and patents linking depression and inflammation at the genetic and cellular level to develop pharmaceutical treatments. Additional info from OTC: |
No news found.